Glucksmann Alexandra

CIK 00016583902 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001658390

Recent Transactions

17 trades

Award
REGENXBIO Inc.$RGNX
Common Stock
2024-05-31+4,790→ 11,286 total
Award
REGENXBIO Inc.$RGNX
Stock Options (Right to Buy)
2024-05-31+24,454→ 24,454 total
Award
REGENXBIO Inc.$RGNX
Common Stock
2023-06-02+3,486→ 6,496 total
Award
REGENXBIO Inc.$RGNX
Stock Options (Right to Buy)
2023-06-02+17,892→ 17,892 total
Award
REGENXBIO Inc.$RGNX
Common Stock
2022-06-03+3,010→ 3,010 total
Award
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2022-06-03+15,324→ 15,324 total
Award
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2021-06-04+10,000→ 10,000 total
Award
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2020-05-29+10,000→ 10,000 total
Award
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2019-05-31+10,000→ 10,000 total
Award
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2018-05-25+25,000→ 25,000 total
Exercise/Conversion
Editas Medicine, Inc.$EDIT
Common Stock
2017-03-15$0.65/sh+1,000→ 118,788 total
Sale
Editas Medicine, Inc.$EDIT
Common Stock
2017-03-15$26.41/sh−1,000→ 117,788 total
Exercise/Conversion
Editas Medicine, Inc.$EDIT
Stock Option (right to buy)
2017-03-15−1,000→ 30,461 total
Exercise/Conversion
Editas Medicine, Inc.$EDIT
Common Stock
2017-02-15$0.65/sh+6,000→ 123,788 total
Sale
Editas Medicine, Inc.$EDIT
Common Stock
2017-02-15$20.00/sh−5,000→ 118,788 total
Exercise/Conversion
Editas Medicine, Inc.$EDIT
Stock Option (right to buy)
2017-02-15−6,000→ 31,461 total
Sale
Editas Medicine, Inc.$EDIT
Common Stock
2017-02-15$23.48/sh−1,000→ 117,788 total

Companies

Recent Filings

Address

C/O EDITAS MEDICINE, INC. 11 HURLEY ST.

CAMBRIDGE, MA, 02141

View on SEC.gov